Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OlympusTSE:7733 +1.40%79 Buyback Yield % is 2.68 as of Jul. 18, 2026, which is 12% below its 10-year median of 3.05. GuruFocus rates TSE:7733 with a GF Score™ of 79/100 and a GF Value™ of 円2,605.18 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Olympus ranks better than 90.78% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Olympus's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7733 vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Olympus's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olympus Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Olympus's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olympus (TSE:7733) has a Buyback Yield % of 2.68 as of Jul. 18, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Olympus and its competitors. This is 12% below median its historical median of 3.05. Over the past decade, Olympus' Buyback Yield % has ranged from 0.27 to 6.97. According to the industry distribution chart, Olympus ranks #32 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 9.2%.
Is Olympus' Buyback Yield % too high?
Olympus' current Buyback Yield % of 2.68 is 12% below median its 10-year median of 3.05. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 6.97. Based on the distribution chart, Olympus ranks #32 out of 347 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Olympus has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olympus' Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Olympus ranks #32 out of 347 companies for Buyback Yield %. This places Olympus in the top 9% of its industry — outperforming the majority of peers. Historically, Olympus' own Buyback Yield % has ranged from 0.27 to 6.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Olympus and its competitors. Olympus's current Buyback Yield % is 2.68, which is 12% below median its own 10-year median of 3.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olympus stock overvalued right now?
Based on GuruFocus' analysis, Olympus (TSE:7733) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,605.18, compared to a current price of 円1,771.50 — trading 32% below its estimated fair value. The current Buyback Yield % is 2.68, which is 12% below median its 10-year median of 3.05. Olympus' overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Olympus (TSE:7733), the current Buyback Yield % is 2.68 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olympus (TSE:7733) Overvalued in 2026?
Based on GuruFocus' analysis, Olympus stock appears to be undervalued.
The current stock price of 円1,771.50 is trading 32% below its estimated GF Value™ of 円2,605.18.
GuruFocus considers Olympus to be Significantly Undervalued.
Key valuation signals for TSE:7733:
Buyback Yield %: 2.68 (12% below median its 10-year median of 3.05)
GF Value™: 円2,605.18 vs. price of 円1,771.50 (32% below fair value)
No single metric tells the full story. See the TSE:7733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
79GF Score
Get the complete analysis for TSE:7733
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7733 has been successfully added to your 
